Effects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation by Choi, Jung Hwa et al.
DOI 10.4110/in.2011.11.1.68
pISSN 1598-2629    eISSN 2092-6685
ORIGINAL ARTICLE
68 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 1 February 2011
Received on January 11, 2011. Revised on January 24, 2011. Accepted on January 28, 2011.
CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribu-
tion, and reproduction in any medium, provided the original work is properly cited.
*Corresponding Author. Tel: 82-2-740-8919; Fax: 82-2-741-8918; E-mail: eycii@snu.ac.kr
Keywords: Irradiation, GVHD, Myeloid cells
Effects of Pre-conditioning Dose on the Immune Kinetics and 
Cytokine Production in the Leukocytes Infiltrating GVHD Tissues 
after MHC-matched Transplantation
Jung Hwa Choi
1, Hyewon Yoon
2, Chang-Ki Min
3 and Eun Young Choi
1*
1Department of Biomedical Sciences, Seoul National University College of Medicine, 
2Department of Nuclear Medicine, Seoul National 
University College of Medicine, Seoul 110-799, 
3Department of Internal Medicine, The Catholic University of Korea, Seoul 137-701, Korea
Background: Graft-versus-host disease (GVHD) is a huddle 
for success of hematopoietic stem cell transplantation. In 
this study, effects of irradiation dose on immune kinetics of 
GVHD were investigated using B6 → BALB.B system, a 
mouse model for GVHD after MHC-matched allogeneic 
transplantation. Methods: BALB.B mice were transplanted 
with bone marrow and spleen cells from C57BL/6 mice after 
irradiation with different doses. Leukocytes residing in the 
peripheral blood and target organs were collected periodi-
cally from the GVHD hosts for analysis of chimerism for-
mation and immune kinetics along the GVHD development 
via flow cytometry. Myeloid cells were tested for production 
of IL-17 via flow cytometry. Results: Pre-conditioning of 
BALB.B hosts with 900 cGy and 400 cGy resulted in differ-
ent chimerism of leukocytes from the blood and affected sur-
vival of GVHD hosts. Profiles of leukocytes infiltrating GVHD 
target organs, rather than profiles of peripheral blood leuko-
cytes (PBLs), were significantly influenced by irradiation 
dose. Proportions of IL-17 producing cells in the infiltrating 
Gr-1
＋ or Mac-1
＋ cells were higher in the GVHD hosts with 
high does irradiation than those with low dose irradiation. 
Conclusion: Pre-conditioning dose affected tissue infiltration 
of leukocytes and cytokine production by myeloid cells in the 
target organs. [Immune Network 2011;11(1):68-78]
INTRODUCTION
Allogeneic hematopoietic stem cell transplantation (HSCT) af-
ter  total  body  irradiation  is  a  common  treatment  for  non-
malignant  and  malignant  hematologic  disorders.  Graft-ver-
sus-host  disease  (GVHD)  is  a  life  threatening  complication 
following  the  treatment  and  a  great  impediment  of  success 
of the HSCT. GVHD is considered to progress through three 
distinct phases (1,2): inflammation induced by irradiation, ac-
tivation of allo-reactive T cells, and then tissue damage in tar-
get organs, such as spleen, liver, lung and intestine, which 
is caused by the activated T cells. Donor-originated T cells 
recognize allo-antigens displayed by host tissues and initiate 
allo-responses  in  the  GVHD  hosts.  Especially,  T  cell  re-
sponses specific for peptides originated from allogeneic minor 
histocompatibility  antigens  play  major  roles  in  induction  of 
GVHD  upon  HSCT  between  MHC-matched  individuals. 
    Pre-conditioning of the recipients of HSCT, total body irra-
diation before the transplantation, is necessary for destroying 
malignant  cells  residing  in  the  recipients,  and  for  creating 
space in the recipient’s bone marrow in order to facilitate the 
engraftment  of  injected  bone  marrow  cells  (3).  Intensity  of 
the total body irradiation, however, correlates with increase 
in risk of GVHD (4). Irradiation with high dose increases sys-
temic inflammatory cytokine and endotoxin levels and drives 
the interaction between DC and donor T cells, leading to se-
vere  GVHD  (5,6). 
    Inflammatory cytokines such as IL-1, TNF-α, and IL-6 have 
been known to be related to increase in GVHD severity (7,8). 
Cytokine profiles of T cells, IFN-γ and IL-4 have also been Effects of Irradiation Intensity on GVHD Immune Kinetics
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demonstrated to be important in the pathogenesis of GVHD 
(9).  IL-17  is  another  inflammatory  cytokine  and  production 
of IL-17 by CD4 T cells play a critical role in triggering in-
flammation and tissue injury in autoimmune diseases (10,11). 
Most of the studies regarding IL-17 in relation to GVHD have 
been  focused  on  the  role  of  CD4  T  cells  producing  IL-17 
(Th17)  with  controversies  over  suppressive  role  or  con-
tribution to local damages (12-14). A human study demon-
strated  that  IL-17  producing  T  cells  contributed  to  acute 
GVHD (15). Although the relationship between the increase 
in inflammatory cytokine levels, especially cytokine secretion 
by T cells, and the severity of GVHD has been well known, 
the role of myeloid cells in GVHD and the production of cy-
tokines  by  those  cells  have  been  obscure. 
    Myeloid cells participate in diverse immune function, sup-
porting or regulating immune responses by producing cyto-
kines, nitric oxide, and reactive oxygen species, etc. And the 
myeloid lineage cells consist of diverse subpopulations: Gr-1
＋ 
and  Mac-1
＋ c e l l s  r e p r e s e n t  g r a n u l o c y t e s  a n d  m a c r o p h a g e s ,  
respectively, and Gr-1
＋ Mac-1
＋ cells, named myelid-derivved 
suppressor cells (MDSC), have recently been identified to be 
a  population  that  can  suppress  T  cell  function  (16).  Since 
GVHD  has  been  considered  as  T  cell-mediated  im-
munopathology in which myeloid cells have rarely been con-
sidered as important factors, detailed studies on myeloid cells 
r e l a t e d  t o  G V H D ,  f o r  e x a m p l e  t h e  k i n e t i c  s t u d y  o r  c o n -
tribution of myeloid cells during GVHD development, have 
rarely  been  done.
    In our previous GVHD study using a MHC-matched mouse 
model (B6 → BALB.B, intravenous injection of bone marrow 
(BM)  cells  and  splenocytes  from  B6  mice  into  irradiated 
BALB.B mice), expansion of CD8 T cells with specificity for 
minor  H  antigens  haves  been  detected  in  peripheral  blood 
and target tissues (17). And immunodominance phenomenon 
has  been  observed  during  the  course  of  GVHD:  that  is, 
among the minor H antigen-specific CD8 T cells, CD8 T cells 
for  H60  dominated  over  those  for  H13  and  HY  during  the 
GHVD progression. Since then, we were interested in the role 
of myeloid cells in GVHD progression, because we observed 
that proportions of Gr-1
＋ cells and Mac-1
＋ cells in the pe-
ripheral blood were high at early time points before CD8 T 
c e l l  e x p a n s i o n  p e r i o d  a n d  l a t e  t i m e  p o i n t s  b e f o r e  m o r b i d  
phase of GVHD hosts. And we presumed that the myeloid 
cells would produce inflammatory cytokines at the early time 
point  and  contribute  to  development  of  GVHD  by  helping 
C D 8  T  c e l l  e x p a n s i o n .  A s  t h e  f i r s t  s t e p  t o  t e s t  t h i s  p r e -
sumption, we chose irradiation for pre-conditioning as an in-
flammation inducing factor and studied the influences of irra-
diation doses on  GVHD development. Two different irradi-
ation doses were selected, which could generate full chimer-
ism  (myeloablative  conditioning)  vs  mixed  chimerism 
(non-myeloablative conditioning) of leukocytes in the B6 → 
BALB.B GVHD hosts and influence GVHD survival. Using the 
two different doses, we compared immune kinetics in blood 
and  target  organs  of  GVHD  hosts,  and  production  of  IL-17 
by the myeloid cell population. The results show that the ef-
fects of different doses of irradiation are more noticeable in 
the leukocytes infiltrating target organs, and IL-17 production 
by myeloid cells is higher in the GVHD hosts that received 
high  dose  irradiation. 
MATERIALS AND METHODS
Mice 
Male C.B10-H2
b/LiMcdJ (BALB.B) and female C57BL/6 (B6) 
mice were obtained from the Jackson Laboratory (Bar Harbor, 
ME, USA) and used as recipients and donor of bone marrow 
(BM) and spleen cells, respectively. Mice were housed under 
specific pathogen-free conditions at the center for animal re-
source development of Seoul National University College of 
Medicine in Korea. All the experiments were performed un-
der approval from The Seoul National University Institutional 
Animal  Care  and  Use  Committee  (IACUC). 
GVHD induction
Bone marrow (BM) cells were prepared from female B6 mice 
by  flushing  femurs  and  tibias  with  1×PBS  (Phosphate  buf-
fered  saline).  Spleen  cells  from  female  B6  mice  were  pre-
pared by grinding spleens through steel mesh. Recipient male 
BALB.B  mice  were  irradiated  with  split  does  from  a 
137Cs 
source  with  a  5  hr  interval.  The  recipient  mice  pre-con-
ditioned either with 900 cGy (myeloablative conditioning) or 
400 cGy (non-myeloablative conditioning) were injected with 
a mixture of B6 BM (5×10
6) and splenocytes (2×10
7) in a 
volume of 300μL into a lateral tail vein after 5 hours after 
the  second  irradiation. 
Preparation of tissue infiltrating leukocytes
BALB.B  GVHD  hosts  were  perfused  with  PBS/heparin  (75 
U/ml; Sigmal, St Louis, MO, USA) before sacrifice to deplete 
circulating peripheral blood leukocytes (PBLs). The prepara-
tion of leukocytes infiltrating livers and lungs was described Effects of Irradiation Intensity on GVHD Immune Kinetics
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Figure 1. Chimerism in the 
peripheral blood leukocytes after 
myeloablative and non-myelo-
ablative pre-conditioning of 
GVHD hosts. Male BALB.B mice
were irradiated under (A) mye-
loablative (900 cGy) or (B) non-
myeloabaltive (400 cGy) irradia-
tion dose 5 hr prior to trans-
plantation with BM cells and 
splenocytes from female B6 
mice, and were bled for testing
leukocyte chimerism on day 4, 7
and 14 after the transplantation. 
PBLs from the 10 hosts in each 
group were pooled and stained 
with anti-Gr-1, Mac-1, CD4 and 
CD8 antibodies in combination 
with anti-β2m
b antibody to 
distinguish the origin of each 
population of leukocytes (leu-
kocytes from B6 mice are β2m
b
positive). Stained cells were ana-
lyzed with flow cytometry 
equipped with CellQuest soft-
ware. Data representing more 
than 5 independent experiments
are shown. 
in detail previously (17). In brief, livers were pressed through 
stainless  steel  mesh  and  suspended  in  5%  fetal  calf  serum 
(FCS)-PBS.  The  cell  suspensions  were  admixed  with  33% 
Percoll  containing  100  U/ml  heparin  and  were  then  cen-
triguged 200 rpm for 15 min at room temperature. The cell 
suspensions were applied to Percoll gradients and RBC lysis, 
and then resuspended in 5% FCS-PBS. Lungs were cut into 
small pieces and treated with collagenase at 37
oC for 30 mi-
nutes  after  washing  with  1×Hanks  balanced  salt  solution 
(HBSS)/HEPES(N-2-hydroxyethylpiperzine-N’-2-ethaaaanesul-
fonic  acid:  10  mM).  Then,  after  washing  twice  with  5% 
FCS-PBS, the cells were applied to Percoll gradients and re-
suspended  in  5%  FCS-PBS  after  washing  with  1×PBS.Effects of Irradiation Intensity on GVHD Immune Kinetics
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Figure 2. Effect of pre-conditioning dose on GVHD severity in B6 → BALB.B model. GVHD was induced by transplantation of BM and splenocytes 
from B6 donor mice into allogeneic BALB.B mice irradiated with myeloablative (900 cGy) or non-myeloablative (400 cGy) dose. The same mixture
of BM and splenocytes of B6 origin was injected into sygeneic B6 mice irradiated with the corresponding doses as control. The recipients of 
the BM and splenocytes were observed for survival and weight changes periodically over 50 days after the transplantation. 
Cell staining and flow cytometry 
Fresh PBLs, splenocytes, or lymphocytes infiltrating livers and 
lungs from the GVHD hosts were incubated at 4
oC for 30 mi-
nutes in FACs buffer (1×PBS with 0.1% bovine calf serum 
and 0.05% sodium azide) containing PE-labeled H60/H-K
b  tet-
ramer and saturating amount of FITC-conjugated anti-CD11a 
(2D7, eBiosicence, San Diego, CA) and APC-conjugated an-
ti-CD8 (eBioscience) monoclonal antibodies. Anti-β2 micro-
globulin B (anti-β2m
b; S19.8, Santa Cruz Biotechnology) anti-
body  was  used  to  distinguish  donor  (B6:β2m
b)-originated 
cells from recipient (BALB.B: β2m
a)-originated ones. Other 
monoclonal antibodies used were PE or APC-conjugated an-
ti-Mac-1  (M1/70,  eBioscience),  FITC-conjugated  anti-Gr-1 
(RB6-8C5,  eBioscience),  PE-conjugated  anti-CD4  (GK1.5, 
eBioscience).  For  intracytoplsmic  staining  for  IFN-γ and 
IL-17 production, cells were stained with anti-Mac-1 or anti- 
Gr-1  antibodies,  washed,  and  then  fixed  with  4%  paraf-
ormaldehyde at room temperate for 20 minutes. After wash-
ing with 1×PBS, the cells were permeabilized with saporine 
and stained with APC-conjugated anti-IFN-γ (XMG1.2, eBio-
science)  or  PE-conjugated  IL-17  (IL-17A;  TC11-18H10,  BD 
Bioscience, San Diego, CA) antibodies at 4
oC for 2 hrs. The 
stained  cells  were  analyzed  using  a  FACSCalibur  equipped 
with  CellQeust  software  (BD  Bioscience).
RESULTS
Irradiation doses corresponding to myeloablative 
and non-myeloablative conditioning in GVHD hosts 
T o se le c t t wo  di ffe re n t ir rad ia ti on  do se s t ha t c or re spo n d t o 
myeloablative  high  intensity  vs  non-myeloablative  mild  in-
tensity doses in the B6 → BALB.B GVHD system, 900 cGy, 
600  cGy,  and  400  cGy  of  irradiation  doses  were  tested  for 
chimerism  formation  in  the  PBLs  of  BALB.B  host  mice. 
BALB.B mice were irradiated with the three different doses, 
t r a n s p l a n t e d  w i t h  B M  a n d  s p l e n o c y t e s  f r o m  B 6  m i c e ,  a n d  
then  eye-bled  on  days  4,  7,  and  14  post-transplantation. 
Pooled PBLs prepared from three BALB.B mice of each group 
w e r e  s t a i n e d  w i t h  a n t i b o d i e s  f o r  m a r k e r  a n t i g e n s ,  G r - 1 ,  
Mac-1, CD4 and CD8, in combination with anti-β2m
b anti-
body to distinguish the cell origins, donor (β2m
b) or recipi-
ent (β2m
a), and then analyzed via flow cytometry. Flow cy-
tometry results showed that, on day 4 after the transplantation 
with 900 cGy irradiation dose, Gr-1
＋, Mac-1
＋, CD4
＋ T cell 
and CD8
＋ T cells in PBL of BALB.B hosts showed mixed chi-
merism,  mixed  with  cells  of  donor  and  recipient  origins. 
However, from day 7, they showed full chimerism with all 
the cell populations replaced with the cells of B6 origin (Fig. 
1). On the contrary, host-originated Gr-1
＋ and Mac-1
＋ pop-
ulations  were  still  detected  in  of  the  PBLs  of  the  BALB.B 
GVHD hosts with irradiation dose of 400 cGy, showing mixed 
chimerism  status,  until  the  day  14  after  the  transplantation, 
w h i l e  m o s t  o f  C D 4  T  a n d  C D 8  T  c e l l s  w e r e  o f  B 6  o r i g i n ,  Effects of Irradiation Intensity on GVHD Immune Kinetics
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Figure 3. PBL profiles of GVHD hosts with different doses of irradiation. PBLs were periodically prepared from the BALB.B hosts that received
BM and splenocytes from B6 mice after myeloablative (900 cGy) or non-meyloablative (400 cGy) irradiation and stained with anti-Gr-1, Mac-1,
CD4, and CD8 antibodies. Percentages of the cells binding to each antibody along the GVHD progression were plotted. The data represent 
more than three independent experiments. 
probably due to expansion of allo-reactive CD4 and CD8 T 
cells of B6 origin in the BALB.B hosts. With 600 cGy of irradi-
ation dose, overall pattern of PBL chimerism was similar to 
that seen in BALB.B recipients with 900 cGy irradiation (data 
not shown). Based upon these results, we selected 900 cGy 
and 400 cGy irradiation doses as myeloablative and non-mye-
loablative conditioning doses, leading to full and mixed-chie-
merism in the PBLs of the BALB GVHD hosts, respectively. 
Correlation between pre-conditioning intensity and 
GVHD severity
Next, we examined the effect of the selected myeloablative 
(900 cGy) and non-myeloablative (400 cGy) irradiation doses 
on GVHD severity in our allogeneic B6 → BALB.B model. 
BALB.B mice which were irradiated under the two different 
conditions  and  transplanted  with  allogeneic  B6  BM  and 
spleen  cells  were  observed  for  their survival  for  ＞50  days 
and regularly checked for their weight changes for 35 days 
after transplantation with BM and splencotyes from B6 mice. 
Syngeneic control transplantation, B6 → B6, was performed 
under  the  same  irradiation  conditions.  Myeloablative  high 
dose  pre-conditioning  and  subsequent  allogeneic  trans-
plantation led to death of BALB.B hosts with drastic weight 
loss  and  other  GVHD  symptoms,  such  as  diarrhea  and 
hunched posture (Fig. 2). With non-myeloablative low dose 
pre-conditioning,  allogeneic  BALB.B  hosts  survived  longer 
than  50  days.  None  of  the  syngeneic  B6  hosts  developed 
GVHD under any circumstatnces. Even though the B6 hosts 
under the myeloablative condition went though weight loss 
early after transplantation, they recovered soon afterward and Effects of Irradiation Intensity on GVHD Immune Kinetics
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survived longer. This result demonstrated that the selected ir-
radiation  does  of  900  cGy  (termed  myeloablative)  and  400 
cGy  (non-myeloablative)  resulted  in  different  outcome  of 
GVHD induction, not only different PBL chimerism in B6 → 
BALB.B system, implying that they are suitable doses for in-
vestigating the irradiation effects on immune kinetics during 
GVHD  development.
Kinetics of peripheral blood leukocytes in GVHD 
hosts with myeloablative vs non-myeloablative 
irradiation 
Then, we compared PBL profiles along the time course after 
GVHD induction between the BALB.B hosts conditioned with 
myeloabltive  vs  non-myeloablative  irradiation,  wondering 
whether PBL profiles would be different depending upon the 
GVHD severity, so that they could be used to distinguish and 
predict  GVHD  outcomes.  Bloods  from the  GVHD  survivors 
of  each  pre-conditioning  group  were  collected  periodically 
and  pooled  for  PBL  preparation.  The  PBLs  were  typed  for 
profiling proportions of Gr-1
＋, Mac-1
＋, CD4
＋ T and CD8
＋ 
T cells in the blood via staining with antibodies specific for 
corresponding antigens and subsequent flow cytometric anal-
ysis, and the proportions of each cell type were plotted as 
kinetics graphs. On the contrary to our expectation, there was 
no big difference in the percentages of Gr-1
＋ or Mac-1
＋ cells 
present in bloods between the myeloabaltively vs non-mye-
loablatively  conditioned  BALB.B  hosts.  Their  fractions 
reached peak, about 90% of PBL, on day 7 after the GVHD 
induction and continued to be high afterward (Fig. 3). The 
kinetics of  CD4
＋ T cells in  the blood was not  significantly 
different between the two groups, either. The only significant 
d i f f e r e n c e  w a s  f o u n d  i n  C D 8  T  c e l l  p o p u l a t i o n :  t h e  p r o -
portion of CD8 T cells in bloods of GVHD hosts was higher 
under  the  myeloablative  (∼12%)  condition  than  the 
non-myeloabative  (4∼7%)  condition  (Fig.  3).  The  results 
from the PBL profile study demonstrated that there was no 
big difference in myeloid cell proportions between the GVHD 
hosts  with  myeloablative  vs  non-myeloablative  irradiation, 
even though the GVHD hosts with the two different pre-con-
ditioning doses experienced different degrees of the disease 
severity. 
Comparison between the profiles of leukocytes that 
infiltrate target organs of GVHS hosts under 
myeloablative vs non-myeloablative conditions
Since the PBLs profiles of GVHD hosts with different doses 
of irradiation were not significantly different, especially con-
sidering  the  proportions  of  myeloid  lineage  cells,  we  ex-
plored the leukocytes that infiltrated into target organs during 
GVHD course, presuming that the infiltration of myeloid cells 
into target tissues might have been influenced by the irradi-
ation doses. Leukocytes infiltrating spleens, livers and lungs 
were  periodically  prepared  from  three  BALB.B  mice  under 
each condition, pooled for staining and subsequent flow cy-
tometry to profile Gr-1
＋, Mac-1
＋, CD4
＋ T and CD8
＋ T cells 
i n  t h e  o r g a n s  a l o n g  t h e  G V H D  c o u r s e .  
    Overall kinetics of the four types of leukocytes infiltrating 
target tissues was significantly different, depending upon the 
pre-conditioning  doses  (Fig.  4).  Proportions  of  Gr-1
＋  cells 
continuously increased in the spleens (Fig. 4A), livers (Fig. 
4B), and lungs (Fig. 4C) of BALB.B hosts with high intensity 
irradiation and accounted for more than 60% of filtrating leu-
kocytes  at  late  time  points  (later  than  day  21  post-trans-
plantation) in the livers and lungs. With low intensity irradi-
ation, the kinetics of Gr-1
＋ infiltrating cells showed patterns 
of early increase followed by decrease in the spleens, livers, 
and lungs of the BALB.B hosts. The kinetics of Mac-1
＋ cells 
was very similar to that of Gr-1
＋ cells residing in all the three 
organs  in  both  myeloabltively  and  non-myeloabltively  con-
ditioned  hosts. 
    Percentages of CD4
＋ T cells reached peak on day 4 (17%), 
day  7  (45%),  and  day  14  (32%)  in  the  spleens,  livers,  and 
lungs of the BALB.B hosts with high intensity irradiation, re-
spectively, and then waned afterward (Fig. 4A-C). This initial 
up and then down pattern of kinetics was observed in the 
case of CD4 T cells infiltrating the tissues of the BALB.B hosts 
with low intensity irradiation, but the peak values were com-
paratively low (14% in spleens, 30 % in livers, and 10% in 
lungs  on  day  4  post-transplantation). 
  Patterns of CD8 T cell kinetics was similar to those of CD4 
T cell in the tissues of the GVHD hosts with myeloablative 
pre-conditioning with peak values of 13% (day 4 post-trans-
plantation), 35% (day 14), and 42% (day 14) in the spleens, 
livers,  and  lungs,  respectively.  In  the  GVHD  hosts  with 
non-myeloablative  pre-conditioning,  proportion  CD8  T  cells 
gradually increased in the spleens with peak values of 12% 
on  day  21  but,  in  the  lungs  and  livers,  they  reached  peak 
on  day  14  post-transplantation. 
    Altogether the results obtained from the profiling of leuko-
c y t e s  i n f i l t r a t i n g  t a r g e t  o r g a n s  o f  G V H D ,  i t  c o u l d  b e  c o n -
cluded that immune kinetics in the target organs is influenced 
by  the  pre-conditioning  intensity.  Among  the  three  organs, Effects of Irradiation Intensity on GVHD Immune Kinetics
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Figure 4. Profiles of leukocytes infiltrating GVH hosts under different irradiation condition. (A) Splenocytes were periodically prepared after 
induction of GVHD under myeloablative (900 cGy) or non-myleoablative (400 cGy) irradiation condition and then stained with anti-Gr-1, Mac-1,
CD4, and CD8 antibodies. Leukocytes infiltrating liver (B) and lung (C) of the GVHD hosts were periodically prepared and stained with the 
antibodies described above. Percentages of Gr-1 positive, Mac-1 positive, CD4 positive, or CD8 positive cells were plotted along the GVHD
progression under different irradiation condition. The data are representative of three independent experiments.Effects of Irradiation Intensity on GVHD Immune Kinetics
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Figure 4. Continued.
liver  and  lung  showed  very  similar  kinetics,  while  spleen 
showed its own kinetics pattern for each cell population, pos-
sibly due to its role as secondary lymphoid organ as well as 
a GVHD target organ. However, on the contrary to our ex-
pectation, proportion of myeloid cells infiltrating spleens and 
lungs cells at early time point (on day 4 post-transplantation) 
was lower in the GVHD hosts with myeloabaltive irradiation 
than non-myeloablative irradiation, for example, 12 % vs 15 
% of Gr-1
＋ cells in the spleens and 17.3 % vs 44% of Gr-1
＋ 
cells in the lungs of myeloabaltively conditioned vs non-mye-
loabaltively  conditioned  hosts,  respectively. 
IL-17 production by Gr-1
＋  or Mac-1
＋ cells that 
infiltrate target organs of GVHD hosts
Even though proportions of myeloid populations in target tis-
sues on day 4 post-transplantation did not correlate with irra-
diation intensities, we wondered whether proportion of cells 
producing  inflammatory  cytokine  in  the  infiltrating  myeloid 
cells would correlate with the irradiation dose. To test this, 
we prepared infiltrating leukocytes from the spleen, liver, and 
lung  on  day  4  after  GVHD  induction  and  analyzed  for  the 
production of IL-17 by Gr-1
＋ or Mac-1
＋ cells. Intracytoplas-
mic staining of the cells with anti-IL-17 and anti-IFN-γ anti-
bodies and subsequence flow cytometry analysis revealed that 
proportions  of  IL-17  producing  cells  in  Gr-1
＋ a n d  M a c - 1
＋ 
cells present in the spleen were higher when the hosts re-
ceived myeloabaltively high dose irradiation than those with 
non-myeloabaltively low dose irradiation (Fig. 5A). They did 
n o t  p r o d u c e  I F N - γ.  Proportion  of  IL-17  producing  Gr-1
＋ 
cells was higher in the spleens (18.7 % on average) than in 
the livers (7.63% on average) or lungs (10.4% on average) 
of the GVHD hosts with myeloablative irradiation (Fig. 5B). 
In the case of Mac-1
＋ cells, proportions of IL-17 producing 
cells were higher in the lungs (16.7% on average) than those 
in the spleens (5.85% on average) and the livers (5.13% on 
average) of the myeloablatively conditioned hosts. In all the 
three organs, proportions of IL-17 producing cells were lower 
in  non-myeloablatively  conditioned  hosts  than  in  the  mye-
loabltively conditioned ones. On day 7 after the GVHD in-
duction, IL-17 production by the myeloid cells that infiltrated 
target  organs  subsided  to  very  low  levels  (Fig.  5B). 
Altogether, these results demonstrate that, even though pro-
portions of Gr-1
＋ or Mac-1
＋ cells was little lower in the tar-
get organs of myeloablatively conditioned hosts than those of Effects of Irradiation Intensity on GVHD Immune Kinetics
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Figure 5. Production of IL-17 by myeloid cells infiltrating target organs of GVHD hosts. Leukocytes infiltrating spleens, livers, and lungs of the
GVHD hosts irradiated with different doses (900 cGy and 400 cGy) were prepared on days 4 and 7 post-transplantation and analyzed for cytokine
production by flow cytometry after intracytoplasmic staining with anti-IFN-γ and IL-17 antibodies in combination with anti-Gr-1 and Mac-1 
antibodies. (A) Representative flow cytometry data obtained from the day 4 samples are shown. (B) The percentages of the IL-17 positive cells 
in the Gr-1 positive cells or Mac-1 positive cells infiltrating the organs were plotted. The data represent three independent experiments. 
non-myeloabaltively conditioned ones at early time points af-
ter GVHD induction, proportions of myeloid cells producing 
inflammatory cytokine IL-17 in the infiltrating cells were high-
er  in  the  former  than  the  latter. Effects of Irradiation Intensity on GVHD Immune Kinetics
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DISCUSSION
In  this  study,  we  investigated  the  effects  of  irradiation 
pre-conditioning dose on the kinetics of leukocytes residing 
in blood and tissues of GVHD hosts, and production of an 
inflammation cytokine, IL-17, by myeloid cells. And the re-
sults showed that different irradiation doses affected kinetics 
of leukocytes infiltrating GVHD target organs and IL-17 pro-
duction  by  the  myeloid  cells.
  B 6  → BALB.B, used in this study, is a mouse model for 
GVHD  occurring  after  BM  transplantation  between  MHC- 
matched unrelated individuals (17). In terms of pathogenesis 
of GVHD, allogeneic T cell activity, especially allo-minor H 
antigen specific CD4 T and CD8 T cells have been considered 
to major  risk  factor, and  the minor  H antigen-reactive CD8 
T  c e l l s  h a v e  b e e n  d e t e c t e d  i n  t h e  b l o o d  a n d  t i s s u e s  o f  
BALB.B GVHD hosts (17). Even though it has been known 
that alloreactive CD8 T cells execute tissue damage in the tar-
get organs, the connection between myeloid cells and the ac-
tivation of allo-reactive T cells has been obscure. Here, our 
data  showed  that  myeloid  cells  actually  produce  cytokine, 
IL-17, in the GVHD target tissues, in response to irradiation 
inflammatory stimulus. Therefore, it could be suggested that 
even though proportions of myeloid cells in blood and target 
organs at early time point after GVHD themselves did not cor-
relate with irradiation intensity, fractions of IL-17 producing 
cells in the tissue infiltrating myeloid cells reflected intensity 
of  pre-conditioning.  Based  on  this  result,  it  could  be  sug-
gested that such difference in the activity of tissue infiltrating 
myeloid cells to produce IL-17 would influence the adaptive 
immunity  in  the  target  tissues  following  the  inflammation 
phase  during  the  GVHD  course,  resulting  in  the  difference 
in the magnitudes of expansion of allo-reactive CD4 T and 
CD8  T  cells  in  the  target  organs  between  the  GVHD  hosts 
with  different  irradiation  doses. 
    IL17  has  been  known  to  be  involved  in  development  of 
some  autoimmune  diseases.  Regarding  the  role  of  IL-17  in 
GVHD, focus has been onto the role of Th17 in GVHD and 
Th17 has been reported to be involved in cutaneous and pul-
monary GVHD in a mouse model (12) and the increase of 
Th 1 7 c el ls o r Tc 17  ce ll s co rr el at ed  wi th  a hi g he r in c id en c e 
of acute GVHD in human study (18). Our result demonstrates 
that  IL-17  can  be  produced  by  myeloid  cells  as  well. 
However, Gr-1
＋ granlocytes and Mac-1
＋ macrophages may 
contribute to GVHD progression in various ways, not just sim-
ply through Il-17 production. They could produce other cyto-
kines, IL-1, IL-16, and TNF, and IFN-γ in responding to irra-
diation  stimulation.  Moreover,  the  myeloid  cells  are  com-
posed of various cell types, including recently identified mye-
loid suppressive cells (Gr-1
＋Mac-1
＋). Therefore, elucidating 
the exact role of myeloid cells to GVHD progression in B6→ 
BALB.B system should await further detailed study including 
dissection of myeloid cells and investigation on their cytokine 
profiles  and  migration  along  the  GVHD  course.   
    The results from PBL profiling study demonstrate that just 
leukocyte typing of PBL does not reflect or predict the GVHD 
severity: there is no big difference in proportions of each leu-
kocyte population between the GVHD hosts with high and 
low  disease  severity,  except  for  CD8  T  cell  population. 
Rather,  significant  difference  in  the  leukocyte  profiles  be-
tween the GVHD hosts with high and low doses irradiation 
was  detected  in  the  leukocytes  infiltrate  target  organs  of 
GVHD,  suggesting  a  close  relationship  between  irradiation 
doses and leukocyte infiltration. In clinic, it is often observed 
that  tumors  relapse in the  GVHD patients  with  mild symp-
toms, who have received non-myeloid conditioning, and the 
relapse occurs in the extra bone marrow tissues (19). Based 
upon our data, this is supposed to be due to reduced infiltra-
tion of inflammatory cytokine producing myeloid cells at ear-
ly time points post-irradiation and hence reduced activity of 
allo-reactive CD8 T cells afterwards, which can help to erad-
icate tumors in the tissues. Therefore, for double purpose of 
s uc c es s o f H SCT  an d c o mp le te  re m iss io n o f t u mo rs ,  a t oo l 
to  control  inflammation  to  help  tissue  infiltration  of  leuko-
cytes to eradicate tumors but avoid adverse GVHD develop-
ment  should  be  developed. 
    In summary, our results demonstrate that pre-conditioning 
dose influence leukocyte infiltration into target organs, result-
ing in different kinetics of leukocyte profiles in GVHD hosts, 
different degrees of  IL-17 production  by  myeloid cells, and 
finally different outcome of GVHD. Investigation on the im-
mune kinetics in detail, including cytokine profiling produced 
in each different target organ and detailed phenotyping of in-
filtrating cells, will enhance the understanding of pathophysi-
ology of GVHD. The results from this study will be helpful 
for  better  understanding  of  pathophysiology  of  GVHD  and 
development of proper method to control GVHD and tumor 
relapse  in  clinic.
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